David G DeNardo

27PUBLICATIONS
216CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Genomics and transcriptomicsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 26, 2026
T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer.

|Mar 20, 2026
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.

Tito A Sandoval, Yize Li, Naoshad Muhammad

|Feb 27, 2026
OmniCellTOSG: The First Cell Text-Omic Signaling Graphs Dataset for Graph Language Foundation Modeling.

Heming Zhang, Tim Xu, Dekang Cao

|Dec 30, 2025
Chemotherapy-induced adipo-lineage cell senescence drives bone loss.

Ganesh Kumar Raut, Taylor Malachowski, Anupama Melam

|Aug 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.

Graham D Hogg, Alyssa G Weinstein, Natalie L Kingston

|Mar 24, 2025
Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer.

Patrick M Grierson, Crystal Wolf, Rama Suresh

Pageof 5

Frequent Collaborators

11 joint publications

Ryan Fields

9 joint publications

Liang-I Kang

8 joint publications

Varintra E Lander

7 joint publications

Graham D Hogg